Free ldl test
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Free LDL Test: Insights from Recent Research
Introduction to LDL and Atherosclerosis
Low-density lipoprotein (LDL) is a type of cholesterol that is often referred to as "bad cholesterol" due to its association with an increased risk of atherosclerosis, a condition characterized by the buildup of fats, cholesterol, and other substances in and on the artery walls. Recent research has focused on the development of assays to measure various forms of LDL and their role in atherosclerosis.
Development of Immunoassays for Anti-Electronegative LDL Autoantibodies
Electronegative LDL and Atherosclerosis
Electronegative LDL (LDL-) is a modified form of LDL that promotes atherosclerosis through inflammatory and immunologic mechanisms. This form of LDL leads to the production of anti-LDL(-) autoantibodies and the formation of immune complexes (IC) and macrophage foam cells, which are critical in the development of atherosclerosis.
ELISA for Free Anti-LDL(-) Autoantibodies
Researchers have developed an enzyme-linked immunosorbent assay (ELISA) for the quantification of free anti-LDL(-) autoantibodies. This assay uses LDL(-) purified from human plasma and anti-LDL(-) monoclonal antibody Fab fragments adsorbed onto ELISA plates to capture these autoantibodies. The calibration range of this assay is 0.004-0.125 mU/l, and it demonstrates dilutional linearity at various dilutions, making it a reliable tool for clinical studies.
ELISA for Immune Complexes
In addition to the free autoantibodies, an ELISA has been developed for the quantification of immune complexes consisting of LDL(-)-bound IgG. This assay has a calibration range of 0.06-4 U/l and also shows dilutional linearity, ensuring its accuracy and precision in measuring these complexes in human plasma.
Cell-Free Assay for Dysfunctional HDL
HDL's Role in Oxidized Phospholipids
High-density lipoprotein (HDL) is known for its protective role against atherosclerosis. A novel cell-free assay has been developed to test HDL's ability to prevent the formation of or inactivate oxidized phospholipids, which are harmful and contribute to the development of atherosclerosis.
Assay Methodology and Findings
This assay measures the fluorescent signal generated in the presence of test substances and HDL. It was found that as little as 2.5 micrograms of normal human HDL cholesterol could significantly inhibit the fluorescent signal generated by oxidized phospholipids. However, HDL from patients with coronary atherosclerosis failed to inhibit this signal, unlike HDL from matched normal subjects, indicating that dysfunctional HDL may play a significant role in the development of atherosclerosis.
Conclusion
The development of these assays represents significant progress in the biochemical investigation of atherosclerosis. The ELISAs for free anti-LDL(-) autoantibodies and immune complexes, along with the cell-free assay for dysfunctional HDL, provide valuable tools for understanding the mechanisms underlying atherosclerosis and potentially guiding clinical interventions. These advancements highlight the importance of both LDL and HDL in cardiovascular health and disease.
Sources and full results
Most relevant research papers on this topic